Rheumnow
ICYMI 2021 Rheumatology Year in Review
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:25:33
- More information
Informações:
Synopsis
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors https://rheumnow.com/news/2021-rheumatology-year-review-172022
